When should I order the serum free light-chain assay, and how should I interpret mild kappa or lambda elevations?
Cleveland Clinic Journal of Medicine · 2026-08 · 93 (8) · 459-462
DOI: 10.3949/ccjm.93a.26009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cleveland Clinic Journal of Medicine, online erschienen am 03.08.2026. Verfasst von Malvinder S Parmar. Beteiligte Einrichtung: Professor, Department of Medicine, Clinical Sciences Division, NOSM University, Sudbury, Ontario, Canada wittykidney@outlook.com.
Abstract (Originalsprache)
Reserve the test for scenarios where a plasma cell disorder is clinically suspected, and interpret mild elevations through the lenses of the kappa:lambda ratio and patient context.
Autor:innen und Institutionen
- Professor, Department of Medicine, Clinical Sciences Division, NOSM University, Sudbury, Ontario, Canada wittykidney@outlook.com.
Zitieren
APA
Parmar, M. S. (2026). When should I order the serum free light-chain assay, and how should I interpret mild kappa or lambda elevations?. Cleveland Clinic Journal of Medicine, 93(8), 459-462. https://doi.org/10.3949/ccjm.93a.26009
Vancouver
Parmar MS. When should I order the serum free light-chain assay, and how should I interpret mild kappa or lambda elevations?. Cleveland Clinic Journal of Medicine. 2026;93(8):459-462. doi:10.3949/ccjm.93a.26009
BibTeX
@article{Parmar2026,
author = {Parmar, Malvinder S},
title = {When should I order the serum free light-chain assay, and how should I interpret mild kappa or lambda elevations?},
journal = {Cleveland Clinic Journal of Medicine},
year = {2026},
volume = {93},
number = {8},
pages = {459--462},
doi = {10.3949/ccjm.93a.26009}
}
EUVIMED